Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies

NCT00718757 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkins Lymphoma
Hodgkin's Disease
Acute Lymphoblastic Leukemia

Interventions

DRUG: Dexamethasone
DRUG: Irinotecan
DRUG: Vincristine

Sponsor

St. Jude Children's Research Hospital